Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mimedx Group Inc (MDXG)

Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
MiMedx Group, Inc. Files Patent Infringement Lawsuit Against Surgenex, LLC

MiMedx filed a lawsuit against Surgenex for alleged patent infringement of placental allograft products, seeking damages and injunction.Quiver AI SummaryMiMedx Group, Inc. has initiated a lawsuit against...

MDXG : 9.10 (+0.22%)
MIMEDX Files Patent Infringement Lawsuit Against Surgenex

MDXG : 9.10 (+0.22%)
MIMEDX to Participate in Upcoming Investor Conferences

MDXG : 9.10 (+0.22%)
MiMedx Group, Inc. Announces Regulatory Changes Impacting Coverage for Skin Substitute Grafts

Revised LCDs will eliminate coverage for over 200 unproven skin substitutes, promoting clinically validated treatments.Quiver AI SummaryMiMedx Group, Inc. announced that over 200 unproven skin substitute...

MDXG : 9.10 (+0.22%)
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MDXG : 9.10 (+0.22%)
MIMEDX to Participate in Upcoming Investor Conferences

MDXG : 9.10 (+0.22%)
MiMedx: Q3 Earnings Snapshot

MiMedx: Q3 Earnings Snapshot

MDXG : 9.10 (+0.22%)
MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MDXG : 9.10 (+0.22%)
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MDXG : 9.10 (+0.22%)
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MDXG : 9.10 (+0.22%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar